Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer

Overview of attention for article published in Oncotarget, July 2016

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 130 Dimensions

Readers on

mendeley: 143 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 130 publications that cite this research output.

130

The most recent citing publications are shown below. View all 130 publications that cite this research output on Dimensions.

TAS3681, an androgen receptor antagonist, prevents drug resistance driven by aberrant androgen receptor signaling in prostate cancer

Article in Molecular Oncology (April 2024)

Mediator kinase inhibition reverses castration resistance of advanced prostate cancer

Article in Journal of Clinical Investigation (March 2024)

Light-switchable diazocines as potential inhibitors of testosterone-synthesizing 17β-hydroxysteroid dehydrogenase 3

Article in Chemico-Biological Interactions (January 2024)